Welcome!
ALERT On Thursday June 27th, 2019 at 5:00 AM (U.S. EST) Agilent Site Reliability Engineers will be working with our Network Service Provider to upgrade the API server for the North American instance. The entire process is expected to be 1 hour, and iLab customers using the API for any features may experience a decrease in performance during this time. More information can be found on the iLab Status Site. For any questions, please contact iLab Support at ilab-support@agilent.com or by clicking on the 'Help' link at the top of your account page.
Mission
The Innovative Translational Research Shared Resource (ITR) at the Vanderbilt-Ingram Cancer Center partners with oncologists, and laboratory and non-laboratory researchers, to guide, manage, and facilitate pre-clinical and clinical trial laboratory discoveries.
Our goal is to advance the translation of research into improved anti-cancer therapies.
Custom projects accepted!
Our broad experience in cancer clinical trials, genomics, biochemistry, and cell biology allows us to pursue your unique research project. We leverage ITR resources, other Vanderbilt Shared Resources, other academic institutions, and/or companies to achieve your goals.
Specific ITR Laboratory Services
The ITR is fully equipped for DNA and RNA isolation from formalin-fixed paraffin-embedded (FFPE) tissues, sample storage, molecular genetics and biochemistry laboratory experimentation, as well as cell culture.
Kimberly Brown Dahlman, Ph.D., Director
kim.dahlman@vanderbilt.edu
615-936-6589 (office); 615-936-0410 (lab)
| Hours | Location |
|
9AM - 5PM, Monday to Friday |
722 Preston Research Building |
